Emmanuelle Mounetou

Antimitotic Antitumor Agents: Synthesis, Structure−Activity Relationships, and Biological Characterization of <i>N</i>-Aryl-<i>N</i>‘-(2-chloroethyl)ureas as New Selective Alkylating Agents

Emmanuelle Mounetou, Jean Legault, Jacques Lacroix et al. · Journal of Medicinal Chemistry · 2001 · 72 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents.

Jean Legault, Jean-François Gaulin, Emmanuelle Mounetou et al. · PubMed · 2000 · 60 citations

Life Sciences, Biochemistry, Pharmacology +17

Development and cytotoxic response of two proliferative MDA-MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines

Clémence Dubois, Robin Dufour, Pierre Daumar et al. · Oncotarget · 2017 · 55 citations · Full text

Medicine, Cell Biology, Oncology +15

Antiangiogenic and Antitumoral Activity of Phenyl-3-(2-Chloroethyl)Ureas

Éric Petitclerc, Réna G. Deschesnes, Marie‐France Côté et al. · Cancer Research · 2004 · 50 citations · Full text

Medicine, Cancer Biology, Medicinal Chemistry +16

BCRP and P-gp relay overexpression in triple negative basal-like breast cancer cell line: a prospective role in resistance to Olaparib

Robin Dufour, Pierre Daumar, Emmanuelle Mounetou et al. · Scientific Reports · 2015 · 41 citations · Full text

Medicine, Oncology, Pharmacology +14